Evaluation of treatment response with PERCIST in follicular lymphoma receiving rituximab single-agent immunotherapy

被引：0
|
作者：
Tatsumi, Mitsuaki [1 ]
Watabe, Tadashi [1 ]
Kato, Hiroki [1 ]
Imaizumi, Masao [1 ]
Shimosegawa, Eku [1 ]
Hatazawa, Jun [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1364
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Single-Agent Rituximab in Treatment-Refractory or Poor Prognosis Patients with Chronic Lymphocytic Leukemia
    Adiga, Giridhar U.
    Wiernik, Peter H.
    BLOOD, 2009, 114 (22) : 940 - 940
  • [42] Dacarbazine as Single-Agent Therapy for Relapsed Lymphoma in Dogs
    Griessmayr, P. C.
    Payne, S. E.
    Winter, J. E.
    Barber, L. G.
    Shofer, F. S.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2009, 23 (06): : 1227 - 1231
  • [43] Treatment of follicular Lymphoma B-cell with rituximab
    Petryk, Gwen
    CANADIAN PHARMACISTS JOURNAL, 2010, 143 : S5 - +
  • [44] Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)
    Rosenbaum, Cara A.
    Jung, Sin-Ho
    Pitcher, Brandelyn
    Bartlett, Nancy L.
    Smith, Sonali M.
    Hsi, Eric
    Wagner-Johnston, Nina
    Thomas, Sachdev P.
    Leonard, John P.
    Cheson, Bruce D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) : 53 - 64
  • [45] Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma
    Hagenbeek, Anton
    Fayad, Luis
    Delwail, Vincent
    Rossi, Jean Francois
    Jacobsen, Eric
    Kuliczkowski, Kazimierz
    Link, Brian K.
    Pinter-Brown, Lauren
    Radford, John
    Hellmann, Andrzej
    Gallop-Evans, Eve
    Gupta, Ira
    Arning, Michael
    Begtrup, Kamilla
    Schultz, Martin
    Bang, Bo
    Russell, Charlotte A.
    Czuczman, Myron S.
    BLOOD, 2009, 114 (22) : 385 - 386
  • [46] Treatment of indolent nonHodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone
    Armitage, JO
    Tobinai, K
    Hoelzer, D
    Rummel, MJ
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (04) : 311 - 321
  • [47] Is single-agent temozolomide the treatment of choice for recurrent primary central nervous system lymphoma?
    Omuro, Antonio Mp
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (09): : 514 - 515
  • [48] Is single-agent temozolomide the treatment of choice for recurrent primary central nervous system lymphoma?
    Antonio MP Omuro
    Nature Clinical Practice Oncology, 2007, 4 : 514 - 515
  • [49] Single-Agent Immunotherapy for Two Types of Cancer in One Patient
    Musher, Benjamin
    Rahal, Ahmad
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (03) : 210 - +
  • [50] AEROSOLIZED CYCLOSPORINE AS SINGLE-AGENT IMMUNOTHERAPY IN CANINE LUNG ALLOGRAFTS
    DOWLING, RD
    ZENATI, M
    BURCKART, GJ
    YOUSEM, SA
    SCHAPER, M
    SIMMONS, RL
    HARDESTY, RL
    GRIFFITH, BP
    SURGERY, 1990, 108 (02) : 198 - 205
12345